Download Free Sample Report

The global Veterinary Pharmaceuticals market size is projected to reach US$ 54.6 billion by 2023, from US$ 31.2 billion in 2029, at a CAGR of 7.3% during 2021-2023.

he research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

• Veterinary Biological Drugs
• Veterinary Preparations
• Others

• Poultry
• Pets
• Other

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
• The Middle East and Africa (Middle East, Africa)
• South and Central America (Brazil, Argentina, Rest of SCA)

• Zoetis(Pfizer)
• MERIAL
• Merial
• Lilly
• Bayer
• Boehringer
• Novartis
• Virbac
• Ceva
• Vetoquinol
• CAHIC
• Ringpu
• Dahuanong
• TECON
• BIOK
• Lukang Pharma
• JINYU Group
• China Animal Healthcare
• Jiangxi Yiling
• JIZHONG Pharmaceutical